<qa>  What is the name of the site that determines the severity of the disease?- Has histologically-cytologically-confirmed, advanced unresectable NSCLC and has measurable disease based on Response Evaluation Criteria in Solid Tumors version 1.1 RECIST 1.1 as determined by the site. 